Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3293 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Paladin files Seasonique NDA in Canada

Paladin signed a license and distribution agreement with Duramed Pharmaceuticals, a wholly owned subsidiary of Barr Pharmaceuticals, which granted Paladin the exclusive Canadian license to market Seasonique. Jonathan

DW Healthcare sells Tandem Labs to LabCorp

Tandem Labs is a bioanalytical and immunoanalytical contract research organization (CRO) supporting pharmaceutical and biotechnology companies with their discovery, preclinical, and clinical drug development programs. The sale of

FDA to review Eisai’s Aciphex sNDA

The FDA has also indicated that the sNDA will receive priority review in accordance with the Best Pharmaceuticals for Children Act, which provides for a 180-day review period.